Parabilis Medicines (PBLS) Q2 2026 earnings results (second quarter 2026)

10-Q filed Aug 13, 2026

Parabilis Medicines (PBLS) reported revenue of $148K for the second quarter 2026 (Q2 2026).

Revenue$148K

Year over year—

Quarter over quarter—

Operating margin—

Net earnings−$52.5M

Parabilis Medicines, Q2 2026: revenue $148K, net loss $52.5M. The chart follows the revenue to costs, profit and cash.

Q2 2026	Amount	Q/Q	Y/Y
Revenue	$148K	—	—
Operating profit	−$50.9M	—	—
Net earnings	−$52.5M	—	—

What changed

Revenue was $148K in Q2 2026.

Operating costs exceeded revenue by $50.9M, an operating margin of -34382.4%. The quarter ended with a net loss of $52.5M.

Parabilis Medicines (PBLS) reported revenue of $148K for the second quarter 2026 (Q2 2026).